|
1
|
Siegel RL, Fedewa SA, Miller KD,
Goding-Sauer A, Pinheiro PS, Martinez-Tyson D and Jemal A: Cancer
statistics for hispanics/latinos, 2015. CA Cancer J Clin.
65:457–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGuire S: World cancer report 2014.
Geneva, Switzerland: World Health Organization, International
Agency for Research on Cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li F, Liu Y, Kan X, Li Y, Liu M and Lu JG:
Elevated expression of integrin alphav and β5 subunit in laryngeal
squamous-cell carcinoma associated with lymphatic metastasis and
angiogenesis. Pathol Res Pract. 209:105–109. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Canis M, Ihler F, Martin A, Wolff HA,
Matthias C and Steiner W: Results of 226 patients with T3 laryngeal
carcinoma after treatment with transoral laser microsurgery. Head
Neck. 36:652–659. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yu ST, Zhou Z, Cai Q, Liang F, Han P, Chen
R and Huang XM: Prognostic value of the C-reactive protein/albumin
ratio in patients with laryngeal squamous cell carcinoma. Onco
Targets Ther. 10:879–884. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu JC, Shen WC, Shih TC, Tsai CW, Chang
WS, Cho Y, Tsai CH and Bau DT: The current progress and future
prospects of personalized radiogenomic cancer study. Biomedicine
(Taipei). 5:22015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tutar L, Tutar E and Tutar Y: MicroRNAs
and cancer; an overview. Curr Pharm Biotechnol. 15:430–437. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Qiu F, Yang L, Ling X, Yang R, Yang X,
Zhang L, Fang W, Xie C, Huang D, Zhou Y and Lu J: Sequence
variation in mature microRNA-499 confers unfavorable prognosis of
lung cancer patients treated with platinum-based chemotherapy. Clin
Cancer Res. 21:1602–1613. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv G, Hu Z, Tie Y, Du J, Fu H, Gao X and
Zheng X: MicroRNA-451 regulates activating transcription factor 2
expression and inhibits liver cancer cell migration. Oncol Rep.
32:1021–1028. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ribeiro-dos-Santos Â, Khayat AS, Silva A,
Alencar DO, Lobato J, Luz L, Pinheiro DG, Varuzza L, Assumpção M,
Assumpção P, et al: Ultra-deep sequencing reveals the microRNA
expression pattern of the human stomach. PLoS One. 5:e132052010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brockway S and Zeleznik-Le NJ: WEE1 is a
validated target of the microRNA miR-17-92 cluster in leukemia.
Cancer Genet. 208:279–287. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim J, Jeong D, Nam J, Aung TN, Gim JA,
Park KU and Kim SW: MicroRNA-124 regulates glucocorticoid
sensitivity by targeting phosphodiesterase 4B in diffuse large B
cell lymphoma. Gene. 558:173–180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhao D, Tu Y, Wan L, Bu L, Huang T, Sun X,
Wang K and Shen B: In vivo monitoring of angiogenesis inhibition
via down-regulation of mir-21 in a VEGFR2-luc murine breast cancer
model using bioluminescent imaging. PLoS One. 8:e714722013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vishnubalaji R, Hamam R, Abdulla MH,
Mohammed MA, Kassem M, Al-Obeed O, Aldahmash A and Alajez NM:
Genome-wide mRNA and miRNA expression profiling reveal multiple
regulatory networks in colorectal cancer. Cell Death Dis.
6:e16142015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang S, Hu F, Liang H, Liu Y, Yang J and
Zhou W: Association between a miRNA-146a polymorphism and
susceptibility to head and neck squamous cell carcinoma in Chinese
patients: A meta-analysis of 8 case-control studies. PLoS One.
12:e01866092017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Heneghan HM, Miller N, Kelly R, Newell J
and Kerin MJ: Systemic miRNA-195 differentiates breast cancer from
other malignancies and is a potential biomarker for detecting
noninvasive and early stage disease. Oncologist. 15:673–682. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Itesako T, Seki N, Yoshino H, Chiyomaru T,
Yamasaki T, Hidaka H, Yonezawa T, Nohata N, Kinoshita T, Nakagawa M
and Enokida H: The microRNA expression signature of bladder cancer
by deep sequencing: The functional significance of the miR-195/497
cluster. PLoS One. 9:e843112014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Collier R: World medical association
updates ethical code for physicians. CMAJ. 189:E13722017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tu Y, Wan L, Fan Y, Wang K, Bu L, Huang T,
Cheng Z and Shen B: Ischemic postconditioning-mediated miRNA-21
protects against cardiac ischemia/reperfusion injury via PTEN/Akt
pathway. PLoS One. 8:e758722013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Justus CR, Leffler N, Ruiz-Echevarria M
and Yang LV: In vitro cell migration and invasion assays. J Vis
Exp. Jun 1–2014.doi: 10.3791/51046. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galoian KA, Guettouche T, Issac B, Qureshi
A and Temple HT: Regulation of onco and tumor suppressor MiRNAs by
mTORC1 inhibitor PRP-1 in human chondrosarcoma. Tumour Biol.
35:2335–2341. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H: Predicting cancer-related MiRNAs
using expression profiles in tumor tissue. Curr Pharm Biotechnol.
15:438–444. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yang X, Yin J, Yu J, Xiang Q, Liu Y, Tang
S, Liao D, Zhu B, Zu X, Tang H and Lei X: miRNA-195 sensitizes
human hepatocellular carcinoma cells to 5-FU by targeting BCL-w.
Oncol Rep. 27:250–257. 2012.PubMed/NCBI
|
|
27
|
Fu MG, Li S, Yu TT, Qian LJ, Cao RS, Zhu
H, Xiao B, Jiao CH, Tang NN, Ma JJ, et al: Differential expression
of miR-195 in esophageal squamous cell carcinoma and miR-195
expression inhibits tumor cell proliferation and invasion by
targeting of Cdc42. FEBS Lett. 587:3471–3479. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chabre O, Libé R, Assie G, Barreau O,
Bertherat J, Bertagna X, Feige JJ and Cherradi N: Serum miR-483-5p
and miR-195 are predictive of recurrence risk in adrenocortical
cancer patients. Endocr Relat Cancer. 20:579–594. 2013.PubMed/NCBI
|
|
29
|
Wang X, Wang J, Ma H, Zhang J and Zhou X:
Downregulation of miR-195 correlates with lymph node metastasis and
poor prognosis in colorectal cancer. Med Oncol. 29:919–927. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jia LF, Wei SB, Gong K, Gan YH and Yu GY:
Prognostic implications of micoRNA miR-195 expression in human
tongue squamous cell carcinoma. PLoS One. 8:e566342013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
He JF, Luo YM, Wan XH and Jiang D:
Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle,
and apoptosis. J Biochem Mol Toxicol. 25:404–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shi W, Du J, Qi Y, Liang G, Wang T, Li S,
Xie S, Zeshan B and Xiao Z: Aberrant expression of serum miRNAs in
schizophrenia. J Psychiatr Res. 46:198–204. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
He X, Ji J, Wang T, Wang MB and Chen XL:
Upregulation of circulating miR-195-3p in heart failure.
Cardiology. 138:107–114. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bhattacharya A, Schmitz U, Wolkenhauer O,
Schonherr M, Raatz Y and Kunz M: Regulation of cell cycle
checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene.
32:3175–3183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Deng H, Guo Y, Song H, Xiao B, Sun W, Liu
Z, Yu X, Xia T, Cui L and Guo J: MicroRNA-195 and microRNA-378
mediate tumor growth suppression by epigenetical regulation in
gastric cancer. Gene. 518:351–359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sun P, Wang L, Lu Y, Liu Y, Li L, Yin L,
Zhang C, Zhao W, Shen B and Xu W: MicroRNA-195 targets VEGFR2 and
has a tumor suppressive role in ACHN cells via PI3K/Akt and
Raf/MEK/ERK signaling pathways. Int J Oncol. 49:1155–1163. 2016.
View Article : Google Scholar : PubMed/NCBI
|
